Adipokine Profile in Patients with Type 2 Diabetes Depends on Degree of Obesity
暂无分享,去创建一个
J. Kocot | P. Dziemidok | I. Musik | M. Kiełczykowska | A. Hordyjewska | G. Szczęśniak | Anna Hordyjewska
[1] C. Ionescu-Tirgoviste,et al. Markers of Oxidative Stress and Antioxidant Defense in Romanian Patients with Type 2 Diabetes Mellitus and Obesity , 2017, Molecules.
[2] G. Dong,et al. [Effect of laparoscopic sleeve gatrectomy on type 2 diabetes mellitus in obese patients with body mass index less than 40 kg/m2]. , 2017, Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery.
[3] Mona Hmoud Al Sheikh,et al. The Determinants of Leptin Levels in Diabetic and Nondiabetic Saudi Males , 2017, International journal of endocrinology.
[4] J. Mejía-Aranguré,et al. Adipokines, insulin resistance, and adiposity as a predictors of metabolic syndrome in child survivors of lymphoma and acute lymphoblastic leukemia of a developing country , 2017, BMC Cancer.
[5] M. Qadir,et al. lep Expression and Its Role in Obesity and Type-2 Diabetes. , 2017, Critical reviews in eukaryotic gene expression.
[6] R. Susilowati,et al. Sexual dimorphism in interleukin 17A and adipocytokines and their association with insulin resistance among obese adolescents in Yogyakarta, Indonesia. , 2016, Asia Pacific journal of clinical nutrition.
[7] E. Sijbrands,et al. Levels of the Soluble Ldl Receptor-relative Lr11 Decrease in Overweight 1 Individuals with Type 2 Diabetes upon Diet-induced Weight Loss 2 3 4 , 2022 .
[8] Guifen Niu,et al. Associations of A-FABP with Anthropometric and Metabolic Indices and Inflammatory Cytokines in Obese Patients with Newly Diagnosed Type 2 Diabetes , 2016, BioMed research international.
[9] S. Wiegand,et al. Leptin but not adiponectin is related to type 2 diabetes mellitus in obese adolescents , 2016, Pediatric diabetes.
[10] J. Bienertová-Vašků,et al. The role of visfatin (PBEF/Nampt) in pregnancy complications. , 2015, Journal of reproductive immunology.
[11] M. Connelly,et al. GlycA, a biomarker of inflammatory glycoproteins, is more closely related to the leptin/adiponectin ratio than to glucose tolerance status. , 2015, Clinical biochemistry.
[12] A. Sriwijitkamol,et al. Cardiometabolic risk in Thai adults with type 2 diabetes mellitus: obese versus non-obese. , 2015, Journal of the Medical Association of Thailand = Chotmaihet thangphaet.
[13] R. Urso,et al. Clinical and biochemical effects of a 3-week program of diet combined with spa therapy in obese and diabetic patients: a pilot open study , 2015, International Journal of Biometeorology.
[14] M. Al-Habori,et al. Association of adipokines, leptin/adiponectin ratio and C-reactive protein with obesity and type 2 diabetes mellitus , 2014, Diabetology & Metabolic Syndrome.
[15] A. Santos-Silva,et al. Adiponectin, Leptin, and Chemerin in Elderly Patients with Type 2 Diabetes Mellitus: A Close Linkage with Obesity and Length of the Disease , 2014, BioMed research international.
[16] X. Gu,et al. Serum leptin levels in obese women with and without type 2 diabetes mellitus. , 2014, Minerva endocrinologica.
[17] K. Lalić,et al. Relationship between Obesity, Adipocytokines and Inflammatory Markers in Type 2 Diabetes: Relevance for Cardiovascular Risk Prevention , 2014, International journal of environmental research and public health.
[18] M. Ghaffari,et al. Additional Effect of Diabetes Mellitus Type 2 on the Risk of Coronary Artery Disease: Role of Serum Adiponectin , 2014, Iranian Red Crescent Medical Journal.
[19] R. Ahima,et al. Resistin in Rodents and Humans , 2013, Diabetes & metabolism journal.
[20] M. Banach,et al. Obesity indices and adipokines in non-diabetic obese patients with early stages of chronic kidney disease , 2013, Medical science monitor : international medical journal of experimental and clinical research.
[21] P. Ismail,et al. Analysis of Gln223Agr Polymorphism of Leptin Receptor Gene in Type II Diabetic Mellitus Subjects among Malaysians , 2013, International journal of molecular sciences.
[22] Vandana Saini,et al. Role of leptin and adiponectin in insulin resistance. , 2013, Clinica chimica acta; international journal of clinical chemistry.
[23] G. Brimas,et al. Comparison of changes in blood glucose, insulin resistance indices, and adipokine levels in diabetic and nondiabetic subjects with morbid obesity after laparoscopic adjustable gastric banding. , 2013, Medicina.
[24] A. Santos-Silva,et al. Adipokines, Oxidized Low-Density Lipoprotein, and C-Reactive Protein Levels in Lean, Overweight, and Obese Portuguese Patients with Type 2 Diabetes , 2013, ISRN obesity.
[25] N. Zarghami,et al. Serum Leptin Level Is Reduced in Non-Obese Subjects with Type 2 Diabetes , 2012, International journal of endocrinology and metabolism.
[26] K. Vivek,et al. Evaluation Of Serum Bio Markers [Leptin, Adiponectin, Crp, Oxidised- Ldl] And Lipid Parameter In Obese With Type-2 Diabetes Mellitus: Risk To CVD , 2013 .
[27] Debojyoti Bhattacharjee,et al. Association of obesity and leptin with insulin resistance in type 2 diabetes mellitus in Indian population. , 2013, Indian journal of physiology and pharmacology.
[28] D. Soliman,et al. Serum visfatin, resistin and IL-18 in A group of Egyptian obese diabetic and non diabetic individuals. , 2013, The Egyptian journal of immunology.
[29] A. Shehzad,et al. Serum Adipokines Metabolic Function and Immunological Correlations in Treated Type 2 Diabetes mellitus and Obese Subjects , 2013 .
[30] A. Kazmi,et al. Association of leptin with type 2 diabetes in non-obese subjects. , 2012, Journal of Ayub Medical College, Abbottabad : JAMC.
[31] M. Hosseinzadeh‐Attar,et al. Elevated serum visfatin levels in patients with acute myocardial infarction. , 2012, Archives of Iranian medicine.
[32] Chia-Jen Tsai,et al. Acute blood glucose fluctuations can decrease blood glutathione and adiponectin levels in patients with type 2 diabetes. , 2012, Diabetes research and clinical practice.
[33] D. Mikhailidis,et al. Plasma visfatin and retinol binding protein-4 levels in patients with type 2 diabetes mellitus and their relationship to adiposity and fatty liver. , 2011, Clinical biochemistry.
[34] A. Vaag,et al. Impact of Physical Inactivity on Adipose Tissue Low-Grade Inflammation in First-Degree Relatives of Type 2 Diabetic Patients , 2011, Diabetes Care.
[35] Yu-Hung Chang,et al. Visfatin in overweight/obesity, type 2 diabetes mellitus, insulin resistance, metabolic syndrome and cardiovascular diseases: a meta‐analysis and systemic review , 2011, Diabetes/metabolism research and reviews.
[36] Lei Qian,et al. Visfatin inhibits apoptosis of pancreatic β-cell line, MIN6, via the mitogen-activated protein kinase/phosphoinositide 3-kinase pathway. , 2011, Journal of molecular endocrinology.
[37] R. Meeusen,et al. © The Author(s) 2010. This article is published with open access at Springerlink.com Communicated by Jacques Poortmans. , 2010 .
[38] N. Zarghami,et al. Serum Resistin Concentration in Obese Diabetic patients: Any Possible Relation to Insulin Resistance Indices? , 2008 .
[39] R. Ahima,et al. Adipokines in obesity. , 2008, Frontiers of hormone research.
[40] J. Bełtowski. Apelin and visfatin: unique "beneficial" adipokines upregulated in obesity? , 2006, Medical science monitor : international medical journal of experimental and clinical research.
[41] S. Yaturu,et al. Resistin and adiponectin levels in subjects with coronary artery disease and type 2 diabetes. , 2006, Cytokine.